Login Register Cart 0
Generic placeholder image

Current Medical Imaging

Editor-in-Chief

ISSN (Print): 1573-4056
ISSN (Online): 1875-6603

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Correlation Between Quantitative Spectral CT Parameters and Ki-67 Expression in Lung Adenocarcinomas Manifesting as Ground-glass Nodules

Author(s): Xin Cao, Hong-guang Hu, Min Shen, Kai Deng and Nan Wu*

Volume 19, Issue 9, 2023

Published on: 03 February, 2023

Article ID: e301222212292 Pages: 11

DOI: 10.2174/1573405619666221230120528

Price: $65

Abstract

Objective: We assessed the feasibility of spectral CT imaging for diagnosing lung adenocarcinomas manifesting as ground-glass nodules (GGNs) with varying Ki-67 expression.

Methods: Spectral CT parameters in 116 patients with lung adenocarcinomas manifesting as GGNs were analyzed. Cases were grouped into pre-invasive/minimally invasive adenocarcinoma (pre/MIA) and invasive adenocarcinoma (IA) groups. The Ki-67 labeling index (Ki-67 LI) was measured and compared between the two groups. Ki-67 LI was divided into three grades based on the number of positive-stained cells. Spectral CT parameters (diameter, water, and iodine concentrations of the lesion [WCL and ICL], the slope of the spectral Hounsfield unit curve [λHU], and CT values from 40 to 140 keV [at 10 keV intervals]) were compared among the three different grades. The correlation between quantitative spectral CT imaging parameters and Ki-67 LI was analyzed using Spearman correlation analysis.

Results: Ki-67 LI in the IA group was significantly higher than in the pre/MIA group (p < 0.01). Grade 2 had higher diameter, WCL, and monochromatic CT values, and grade 1 had higher ICL and λHU. The WCL and monochromatic CT values were highly and positively correlated with Ki-67 LI. CT40keV had the highest correlation with Ki-67 LI, the diameter was moderately correlated with Ki- 67 LI, and ICL and λHU were weakly correlated with Ki-67 LI.

Conclusion: Spectral CT, a noninvasive diagnostic method, is valuable for predicting Ki-67 expression higher in IA, thus allowing preoperative evaluation of lung adenocarcinomas manifesting as GGNs.

[1]
Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner Society: Glossary of terms for thoracic imaging. Radiology 2008; 246(3): 697-722.
[http://dx.doi.org/10.1148/radiol.2462070712] [PMID: 18195376]
[2]
Eguchi T, Kondo R, Kawakami S, et al. Computed tomography attenuation predicts the growth of pure ground-glass nodules. Lung Cancer 2014; 84(3): 242-7.
[http://dx.doi.org/10.1016/j.lungcan.2014.03.009] [PMID: 24681281]
[3]
Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011; 6(2): 244-85.
[http://dx.doi.org/10.1097/JTO.0b013e318206a221] [PMID: 21252716]
[4]
Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization classification of lung tumors. J Thorac Oncol 2015; 10(9): 1243-60.
[http://dx.doi.org/10.1097/JTO.0000000000000630] [PMID: 26291008]
[5]
Nicholson AG, Tsao MS, Beasley MB, et al. The 2021 WHO classification of lung tumors: Impact of advances since 2015. J Thorac Oncol 2022; 17(3): 362-87.
[http://dx.doi.org/10.1016/j.jtho.2021.11.003] [PMID: 34808341]
[6]
Scholzen T, Gerdes J. The Ki-67 protein: From the known and the unknown. J Cell Physiol 2000; 182(3): 311-22.
[http://dx.doi.org/10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9] [PMID: 10653597]
[7]
Martin B, Paesmans M, Mascaux C, et al. Ki-67 expression and patients survival in lung cancer: Systematic review of the literature with meta-analysis. Br J Cancer 2004; 91(12): 2018-25.
[http://dx.doi.org/10.1038/sj.bjc.6602233] [PMID: 15545971]
[8]
Yamashita S, Moroga T, Tokuishi K, et al. Ki-67 labeling index is associated with recurrence after segmentectomy under video-assisted thoracoscopic surgery in stage I non-small cell lung cancer. Ann Thorac Cardiovasc Surg 2011; 17(4): 341-6.
[http://dx.doi.org/10.5761/atcs.oa.10.01573] [PMID: 21881319]
[9]
Sofocleous CT, Garg SK, Cohen P, et al. Ki 67 is an independent predictive biomarker of cancer specific and local recurrence-free survival after lung tumor ablation. Ann Surg Oncol 2013; 20(S3): 676-83.
[http://dx.doi.org/10.1245/s10434-013-3140-1] [PMID: 23897007]
[10]
Shimizu K, Yamada K, Saito H, et al. Surgically curable peripheral lung carcinoma: Correlation of thin-section CT findings with histologic prognostic factors and survival. Chest 2005; 127(3): 871-8.
[http://dx.doi.org/10.1378/chest.127.3.871] [PMID: 15764770]
[11]
Min JH, Lee HY, Lee KS, et al. Stepwise evolution from a focal pure pulmonary ground-glass opacity nodule into an invasive lung adenocarcinoma: An observation for more than 10 years. Lung Cancer 2010; 69(1): 123-6.
[http://dx.doi.org/10.1016/j.lungcan.2010.04.022] [PMID: 20478641]
[12]
Peng M, Peng F, Zhang C, et al. Preoperative prediction of Ki-67 labeling index by three-dimensional CT image parameters for differential diagnosis of Ground-Glass Opacity (GGO). PLoS One 2015; 10(6): e0129206.
[http://dx.doi.org/10.1371/journal.pone.0129206] [PMID: 26061252]
[13]
Chen M, Li X, Wei Y, Qi L, Sun YS. Spectral CT imaging parameters and Ki-67 labeling index in lung adenocarcinoma. Chin J Cancer Res 2020; 32(1): 96-104.
[http://dx.doi.org/10.21147/j.issn.1000-9604.2020.01.11] [PMID: 32194309]
[14]
Lin L, Cheng J, Tang D, et al. The associations among quantitative spectral CT parameters, Ki-67 expression levels and EGFR mutation status in NSCLC. Sci Rep 2020; 10(1): 3436.
[http://dx.doi.org/10.1038/s41598-020-60445-0] [PMID: 32103127]
[15]
Dou P, Liu Z, Xie L, et al. The predictive value of energy spectral CT parameters for assessing Ki-67 expression of lung cancer. Transl Cancer Res 2020; 9(7): 4267-78.
[http://dx.doi.org/10.21037/tcr-19-2769a] [PMID: 35117793]
[16]
Silva AC, Morse BG, Hara AK, Paden RG, Hongo N, Pavlicek W. Dual-energy (spectral) CT: Applications in abdominal imaging. Radiographics 2011; 31(4): 1031-46.
[http://dx.doi.org/10.1148/rg.314105159] [PMID: 21768237]
[17]
Naidich DP, Bankier AA, MacMahon H, et al. Recommendations for the management of subsolid pulmonary nodules detected at CT: A statement from the Fleischner Society. Radiology 2013; 266(1): 304-17.
[http://dx.doi.org/10.1148/radiol.12120628] [PMID: 23070270]
[18]
Han L, Zhang P, Wang Y, et al. CT quantitative parameters to predict the invasiveness of lung pure ground-glass nodules (pGGNs). Clin Radiol 2018; 73(5): 504.e1-7.
[http://dx.doi.org/10.1016/j.crad.2017.12.021] [PMID: 29397913]
[19]
Son JY, Lee HY, Kim JH, et al. Quantitative CT analysis of pulmonary ground-glass opacity nodules for distinguishing invasive adenocarcinoma from non-invasive or minimally invasive adenocarcinoma: The added value of using iodine mapping. Eur Radiol 2016; 26(1): 43-54.
[http://dx.doi.org/10.1007/s00330-015-3816-y] [PMID: 25981222]
[20]
Tabata K, Tanaka T, Hayashi T, et al. Ki-67 is a strong prognostic marker of non-small cell lung cancer when tissue heterogeneity is considered. BMC Clin Pathol 2014; 14(1): 23.
[http://dx.doi.org/10.1186/1472-6890-14-23] [PMID: 24860257]
[21]
Jakobsen JN, Sørensen JB. Clinical impact of ki-67 labeling index in non-small cell lung cancer. Lung Cancer 2013; 79(1): 1-7.
[http://dx.doi.org/10.1016/j.lungcan.2012.10.008] [PMID: 23137549]
[22]
Hommura F, Dosaka-Akita H, Mishina T, et al. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers. Clin Cancer Res 2000; 6(10): 4073-81.
[PMID: 11051259]
[23]
Li M, Wu N, Zhang L, et al. Solid component proportion is an important predictor of tumor invasiveness in clinical stage T1N0M0 (cT1N0M0) lung adenocarcinoma. Cancer Imaging 2018; 18(1): 18.
[http://dx.doi.org/10.1186/s40644-018-0147-7] [PMID: 29728140]
[24]
Fan L, Fang M, Li Z, et al. Radiomics signature: a biomarker for the preoperative discrimination of lung invasive adenocarcinoma manifesting as a ground-glass nodule. Eur Radiol 2019; 29(2): 889-97.
[http://dx.doi.org/10.1007/s00330-018-5530-z] [PMID: 29967956]
[25]
Migliore M, Fornito M, Palazzolo M, et al. Ground glass opacities management in the lung cancer screening era. Ann Transl Med 2018; 6(5): 90.
[http://dx.doi.org/10.21037/atm.2017.07.28] [PMID: 29666813]
[26]
Van Schil PE. Surgery compared to stereotactic body radiation therapy for early-stage non-small cell lung cancer: Better, equivalent or worse? J Thorac Dis 2017; 9(11): 4230-2.
[http://dx.doi.org/10.21037/jtd.2017.10.36] [PMID: 29268479]
[27]
Wang Y, Zheng D, Zheng J, et al. Predictors of recurrence and survival of pathological T1N0M0 invasive adenocarcinoma following lobectomy. J Cancer Res Clin Oncol 2018; 144(6): 1015-23.
[http://dx.doi.org/10.1007/s00432-018-2622-8] [PMID: 29532227]
[28]
Li Q, Fan L, Cao ET, Li QC, Gu YF, Liu SY. Quantitative CT analysis of pulmonary pure ground-glass nodule predicts histological invasiveness. Eur J Radiol 2017; 89: 67-71.
[http://dx.doi.org/10.1016/j.ejrad.2017.01.024] [PMID: 28267551]
[29]
Ikeda K, Awai K, Mori T, Kawanaka K, Yamashita Y, Nomori H. Differential diagnosis of ground-glass opacity nodules: CT number analysis by three-dimensional computerized quantification. Chest 2007; 132(3): 984-90.
[http://dx.doi.org/10.1378/chest.07-0793] [PMID: 17573486]
[30]
Bak SH, Lee HY, Kim JH, et al. Quantitative CT scanning analysis of pure ground-glass opacity nodules predicts further CT scanning change. Chest 2016; 149(1): 180-91.
[http://dx.doi.org/10.1378/chest.15-0034] [PMID: 26313232]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy